Advertisement

FDG PET/CT in Evaluating Osteomyelitis and Diabetic Foot

  • Alok Pawaskar
  • Sandip Basu
Chapter
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

FDG PET/CT has demonstrated promising results for imaging of osteomyelitis. It is a useful adjunct to MRI in doubtful cases. It surpasses performance of MRI is spinal infections and can significantly add to the clinical workup of diabetic foot. Its ability to assess soft tissue, skeletal, vascular, and neurological (Charcot joints) complications in a single examination may make it a preferred investigational tool in conjunction with MRI. PET-MRI as a modality may evolve in this regard. However, these aspirations need strengthening with larger prospective research studies in future.

References

  1. 1.
    Bleeker-Rovers CP, Vos FJ, Corstens FH, Oyen WJ. Imaging of infectious diseases using [18F] fluorodeoxyglucose PET. Q J Nucl Med Mol Imaging. 2008;52(1):17–29.PubMedGoogle Scholar
  2. 2.
    de Winter F, van de Wiele C, Vogelaers D, de Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am. 2001;83-A(5):651–60.CrossRefPubMedGoogle Scholar
  3. 3.
    Hartmann A, Eid K, Dora C, Trentz O, von Schulthess GK, Stumpe KD. Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur J Nucl Med Mol Imaging. 2007;34(5):704–14.CrossRefPubMedGoogle Scholar
  4. 4.
    Termaat MF, Raijmakers PG, Scholten HJ, Bakker FC, Patka P, Haarman HJ. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and metaanalysis. J Bone Joint Surg Am. 2005;87(11):2464–71.PubMedGoogle Scholar
  5. 5.
    Hess S, Hansson SH, Pedersen KT, Basu S, Høilund-Carlsen PF. FDG-PET/CT in infectious and inflammatory diseases. PET Clin. 2014;9:497–519.CrossRefPubMedGoogle Scholar
  6. 6.
    Gemmel F, Rijk PC, Collins JM, Parlevliet T, Stumpe KD, Palestro CJ. Expanding role of 18F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections. Eur Spine J. 2010;19(4):540–51.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Demirev A, Weijers R, Geurts J, Mottaghy F, Walenkamp G, Brans B. Comparison of [18 F]FDG PET/CT and MRI in the diagnosis of active osteomyelitis. Skelet Radiol. 2014;43(5):665–72.CrossRefGoogle Scholar
  8. 8.
    Vos FJ, Kullberg BJ, Sturm PD, et al. Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia. Medicine. 2012;91(2):86–94.CrossRefPubMedGoogle Scholar
  9. 9.
    Schmitz A, Risse JH, Grunwald F, Gassel F, Biersack HJ, Schmitt O. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. Eur Spine J. 2001;10(6):534–9.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Stumpe KD, Zanetti M, Weishaupt D, Hodler J, Boos N, Von Schulthess GK. FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. AJR Am J Roentgenol. 2002;179(5):1151–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Hungenbach S, Delank KS, Dietlein M, Eysel P, Drzezga A, Schmidt MC. 18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis. Nucl Med Commun. 2013;34(11):1068–74.CrossRefPubMedGoogle Scholar
  12. 12.
    Prodromou ML, Ziakas PD, Poulou LS, Karsaliakos P, Thanos L, Mylonakis E. FDG PET is a robust tool for the diagnosis of spondylodiscitis: a meta-analysis of diagnostic data. Clin Nucl Med. 2014;39(4):330–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19:377–84. PMID:12027925.CrossRefPubMedGoogle Scholar
  14. 14.
    Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22:157–62.CrossRefPubMedGoogle Scholar
  15. 15.
    Marcus CD, Ladam-Marcus VJ, Leone J, et al. MR imaging of osteomyelitis and neuropathic osteoarthropathy in the feet of diabetics. Radiographics. 1996;16:1337–48.CrossRefPubMedGoogle Scholar
  16. 16.
    Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis. 2008;47(4):519–27.CrossRefPubMedGoogle Scholar
  17. 17.
    Nawaz A, Torigian DA, Siegelman ES, et al. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol. 2010;12:335–42.CrossRefPubMedGoogle Scholar
  18. 18.
    Basu S, Chryssikos T, Houseni M, et al. Potential role of FDG-PET in the setting of diabetic neuroosteoarthropathy: can it differentiate uncomplicated Charcot’s neuropathy from osteomyelitis and soft tissue infection? Nucl Med Commun. 2007;28:465–72.CrossRefPubMedGoogle Scholar
  19. 19.
    Basu S, Zhuang H, Alavi A. Imaging of lower extremity artery atherosclerosis in diabetic foot: FDG-PET imaging and histopathological correlates. Clin Nucl Med. 2007;32(7):567–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Basu S, Shah J, Houseni M, et al. Uptake in the lower extremity arteries in diabetic foot with ischemic complications and neuropathic osteoarthropathy: FDG PET and histopathological correlation. Clin Nucl Med. 2007;33(1):74–80. [Abstracts from the ACNP34th Annual Meeting, February 15-18, 2007, San Antonio, Texas].Google Scholar
  21. 21.
    Riccio SA, Chu AK, Rabin HR, Kloiber R. Fluorodeoxyglucose positron emission tomography/computed tomography interpretation criteria for assessment of antibiotic treatment response in pyogenic spine infection. Can Assoc Radiol J. 2015;66(2):145–52.CrossRefPubMedGoogle Scholar
  22. 22.
    Nanni C, Boriani L, Salvadori C, et al. FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging. 2012;39(10):1538–44.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Alok Pawaskar
    • 1
    • 2
  • Sandip Basu
    • 1
    • 3
  1. 1.Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre AnnexeMumbaiIndia
  2. 2.HCG Manavata Cancer CentreNashikIndia
  3. 3.Homi Bhabha National InstituteMumbaiIndia

Personalised recommendations